Report Tracks How Fitness Operators Are Responding to the Rise of GLP-1 Medications
Krissy Vann | Host, All Things Fitness and Wellness
A new industry report suggests the intersection between GLP-1 weight loss medications and the fitness sector is accelerating, as more operators explore ways to integrate clinical weight management into traditional club offerings.
Education technology company Inspire360 has released its Q1 2026 GLP-1 Club Intelligence Report, an analysis that tracks how fitness operators and solution providers are responding to growing demand from members using GLP-1 medications. According to the report, 17 fitness clubs and 10 solution providers had taken concrete steps in the space as of March 2026.
The report points to what it describes as the continued expansion of a “fitness-as-medicine” model, with different segments of the industry approaching the opportunity in distinct ways. Some premium operators are introducing direct clinical partnerships or integrated weight management programs, while more value-focused chains are exploring telehealth referral models.
Inspire360’s analysis also notes that operators are navigating a changing regulatory landscape. Recent enforcement actions from the U.S. Food and Drug Administration targeting certain compounded GLP-1 alternatives have created additional compliance considerations for companies offering weight management programs tied to the medications.
At the same time, the report highlights potential new revenue opportunities tied to healthcare policy. The Centers for Medicare & Medicaid Services recently introduced the BALANCE Model, which requires Medicare and Medicaid patients using GLP-1 medications to participate in lifestyle support programs. The initiative could allow fitness organizations that qualify as “authorized lifestyle providers” to participate in reimbursable programs, with Medicaid coverage potentially beginning as early as May 2026.
The report also outlines the scale of the emerging market. Inspire360 cites data suggesting approximately 12.4 percent of U.S. adults have now taken a GLP-1 medication, and roughly half of those individuals say they would consider joining a gym to support their weight management efforts.
Industry partnerships are also expanding as companies build infrastructure to support these programs. The report points to solution providers such as NexGen MD and Dr. B, which are working with fitness brands including UFC GYM, F45, and Planet Fitness to support clinical weight management initiatives.
One area the report identifies as a challenge for the industry is trainer education. While many GLP-1-related programs emphasize resistance training to help prevent muscle loss during weight reduction, the report notes that standardized training for fitness professionals in this area remains limited.
“Every program in this report emphasizes the same thing: GLP-1 users need qualified fitness professionals,” said Jason Davis, chief executive officer of Inspire360.
Davis said Inspire360 plans to address what the report calls a “trainer readiness gap” through a new specialty certification developed with clinical experts. The program is intended to help trainers understand appropriate scope of practice and training considerations when working with members who are using GLP-1 medications.
The company says improving education around these protocols could help fitness professionals better support resistance training and metabolic health strategies for individuals undergoing medically supported weight loss.
The full report is available through Inspire360.
